One prominent example of a viral vector-based vaccine is PANVAC, a recombinant poxvirus vaccine designed to express two tumor-associated antigens: carcinoembryonic antigen (CEA) and mucin 1 (MUC1) [250]. Here, CEACAM5 is linked to neoplasm.